Lyric, an AI-first healthcare technology company, and Autonomize AI, an emerging leader in Generative AI solutions, have announced a strategic partnership designed to enhance health care efficiency and transparency. This alliance will bring Autonomize AI's secure, trusted generative AI technology to Lyric's extensive network of customers, via Lyric's innovative AIaaS solution, Lyric IQ.
PHILADELPHIA, Oct. 24, 2023 /PRNewswire-PRWeb/ -- Lyric, an AI-first healthcare technology company, and Autonomize AI, an emerging leader in Generative AI solutions, have announced a strategic partnership designed to enhance healthcare efficiency and transparency. This alliance will bring Autonomize AI's secure, trusted generative AI technology to Lyric's extensive network of customers.
"Health care is complex and so is its data. Our partnership with Autonomize AI is set to be a game changer. Together, we will simplify the business of care by efficiently scaling knowledge work for our customers," said Rajeev Ronanki, Lyric's Chief Executive Officer. "Lyric will continue to bring best-in-breed solutions to customers, either by building capabilities or partnering with market-leading companies. Our partnership with Autonomize AI is just one more example of how we're leveraging the power of machine learning, AI, and predictive analytics to provide our customers with pathways to increased accuracy and efficiency, while maximizing value and savings."
With this partnership, Lyric will offer Autonomize AI "co-pilots" to customers via LyricIQ, enhancing the effectiveness and efficiency of administrative staff functions in healthcare payer settings. This approach not only boosts operational efficiency but enables administrative teams to focus more on strategic tasks, alleviating the increasing challenges of workforce burnout and staffing deficits in the sector.
Potential use cases include:
- Prior Authorization: AI co-pilots swiftly pre-validate claims by analyzing medical records and guidelines, expediting approvals and reducing manual effort.
- Care Gap Identification and Closure: AI co-pilots scan unstructured clinical and member data to spot missed care opportunities, facilitating precise interventions to close gaps.
- Risk and Quality Assessments: AI co-pilots use machine learning to classify risk and assess care quality, guiding targeted actions for better outcomes.
- Case Management: AI co-pilots can expedite and aggregate data collection from diverse sources to assemble thorough case summaries, aiding case managers in making informed decisions.
As pioneers at the intersection of technology and health care, Lyric and Autonomize AI are setting new standards in health care through AI. "The fusion of our advanced generative AI technology with Lyric's clinical content and payment accuracy expertise promises a new era in health care," explained Ganesh Padmanabhan, CEO of Autonomize AI. "Our combined capabilities have the potential to greatly reduce the administrative burden for health plans and healthcare organizations. This will not only improve operational efficiencies but also fundamentally enhance the patient care experience."
About Lyric:
Lyric, formerly ClaimsXten is a leading AI healthcare technology company, committed to simplifying the business of care. Over 30 years of experience, dedicated, expert teams, and top technologies help deliver up to $14 billion of annual savings to our many loyal and valued customers—including 9 of the top 10 payers across the country. Lyric's solutions leverage the power of machine learning, AI, and predictive analytics to empower health plan payers with pathways to increased accuracy and efficiency, while maximizing value and savings. Discover more at Lyric.ai.
About LyricIQ:
LyricIQ's AI module collects and evaluates customer data through a secure and straightforward integration. This process identifies claims trends and forms predictive models for a comprehensive review. Leveraging AI-generated insights, Lyric's seasoned team of data scientists and clinical experts identify potential opportunities for payment error reductions, substantial cost savings, and future value realization. LyricIQ cuts through the clutter, offering a consolidated best-of-breed solution that not only focuses on data quality and algorithmic bias but also deploys AI in a responsible, ethical manner. The LyricIQ platform creates unparalleled return on investment for customers by integrating industry-leading pre-pay editing offerings—currently employed by over one hundred and ten health plans—into a seamless, end-to-end solution.
With the implementation of LyricIQ's advanced technological capabilities, the timeline for data review, collection, and realization of savings is drastically reduced, transforming years and months into mere weeks.
About Autonomize AI:
Going beyond the boundaries of traditional data analytics, Autonomize AI excels in organizing, contextualizing, and summarizing unstructured data. This empowers healthcare knowledge teams to seamlessly automate a range of tasks, from administrative procedures to clinical workflows. Leveraging trusted generative AI within a secure and reliable framework, Autonomize AI serves as the ultimate AI co-pilot for organizations looking to efficiently scale their knowledge work. Autonomize AI is a founding member of CancerX, President Biden's Cancer Moonshot initiative. Our customers include Top 20 pharma, F100 Payers and life sciences companies. Visit autonomize.ai to learn more.
Media Contact
Amy Churchill, Lyric, 1 7248414450, [email protected], lyric.ai
SOURCE Lyric
Share this article